Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot Study

Table 1

Patient characteristics: Diagnose, Treatment, and Stage.

Patients	Age (years)	Gender	Tumour type	Treatment	Post operative stage	Post operative Hb (g/dL)
1	67	F	Atypical carcinoid tumour	Pneumonectomy + Chemotherapy	III A	9.7
2	51	M	NSCLC	Chemotherapy + Radiotherapy	III B	13.1
3	53	M	NSCLC	Pneumonectomy	II A	13.7
4	54	M	Pleural mesothelioma	Pneumonectomy + Chemotherapy + Radiotherapy	III	12.8
5	66	M	NSCLC	Pneumonectomy + Chemotherapy	III A	11.7
6	79	M	NSCLC	Pneumonectomy	III B	11.2
7	66	M	Pleural mesothelioma	Pneumonectomy + Chemotherapy + Radiotherapy	III	12.9
8	66	F	NSCLC	Lobectomy	I B	13.8
9	58	M	NSCLC	Lobectomy + Chemotherapy	III B	14.6
10	70	M	NSCLC	Lobectomy + Radiotherapy	IB	10.8
11	61	M	Pleural mesothelioma	Pneumonectomy +Chemotherapy + Radiotherapy	III	10
12	55	M	NSCLC	Lobectomy + Radiotherapy	IIB	12.4
13	62	M	NSCLC	Pneumonectomy	IIIB	15.5
14	51	M	Pleural mesothelioma	Pneumonectomy +Chemotherapy + Radiotherapy	III	14.6
15	64	F	NSCLC	Radiotherapy	IA	15.8
16	64	M	Typical carcinoid tumour	Bilobectomie	IA	13

NSCLC: Non Small Cell Lung Cancer.